ID: ALA3706536

Max Phase: Preclinical

Molecule Type: Unknown

Alternative Forms

1. Parent:

   

   ALA3706536

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

References

1. Hardy KD, Wahlin MD, Papageorgiou I, Unadkat JD, Rettie AE, Nelson SD..  (2013)  Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells.,  42  [PMID:24191259] [10.1124/dmd.113.054817]

Source

Source(1):

• Curated Drug Metabolism Pathways